-
SpeichernDas Eingabefeld wird
gespeichert wenn Sie das Feld
verlassen oder hier klicken.Börse Börse FrankfurtSymbol NOVC-
Novo Nordisk A/SBörse Börse FrankfurtSymbol NOVC
-
Novo Nordisk A/SBörse Börse FrankfurtSymbol NOVA
-
Novo Nordisk A/SBörse Börse MünchenSymbol NOVA
-
Novo Nordisk A/SBörse Börse MünchenSymbol NOVC
-
Novo Nordisk A/SBörse Börse BerlinSymbol NOVC
-
Novo Nordisk A/SBörse Börse BerlinSymbol NOVA
-
Novo Nordisk A/SBörse Börse DüsseldorfSymbol NOVA
-
Novo Nordisk A/SBörse Tradegate System der Deutsche Börse AG (60%)Symbol NOVA
-
Novo Nordisk A/SBörse Quotrix System der Börse DüsseldorfSymbol NOVA
-
Novo Nordisk A/SBörse Börse StuttgartSymbol NOVA
-
Novo Nordisk A/SBörse Tradegate System der Deutsche Börse AG (60%)Symbol NOVC
-
Novo Nordisk A/SBörse Börse StuttgartSymbol NOVC
-
Novo Nordisk A/SBörse Gettex System der Börse MünchenSymbol NOVC
-
Novo Nordisk A/SBörse Quotrix System der Börse DüsseldorfSymbol NOVC
-
Novo Nordisk A/SBörse Börse DüsseldorfSymbol NOVC
-
Novo Nordisk A/SBörse Gettex System der Börse MünchenSymbol NOVA
-
Novo Nordisk A/SBörse Börse Stuttgart
-
Novo Nordisk A/SBörse Börse Stuttgart
-
Novo Nordisk A/S ADRBörse NYSE New York Stock ExchangeISIN US6701002056 WKN: 866931Symbol NVO
-
NOVO NORDISK A/S-BBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"ISIN DK0060534915 WKN: A1XA8RSymbol NOVOB
-
Novo Nordisk A/S BBörse NYSE New York Stock ExchangeISIN DK0060534915 WKN: A1XA8RSymbol NOVO-B
-
NOVO NORDISK A/S-BBörse Amerikanscher Freiverkehr OTC oder "Pink Sheets"Symbol NOVC
-
Novo Nordisk A/S BBörse OMXC Copenhagen Stock ExchangeISIN DK0060534915 WKN: A1XA8RSymbol NOVO B
-
ISIN DK0060534915
-
MXN
-
Symbol NOVC
-
Symbol NOVA
-
Novo NordiskBörse London Stock Exchange
-
Novo Nordisk A/SBörse Freiverkehr OTC
-
Novo Nordisk outperformed den DAX um +67 % vom 30.09.2013 bis 08.05.2015
Die letzten Quartalsergebnisse Erwarteter Gewinn je Aktie beim aktuellen Wert von
Portrait der Novo Nordisk Aktie
Das Unternehmen Novo Nordisk aus Dänemark ist in den Bereichen Chemie & Pharma, Einzelhandel (Medikamente), Einzelhandel, Pharma tätig.
Die Novo Nordisk Aktie konnte seit dem 30.09.2013 eine Rendite von 101% erwirtschaften.
Novo Nordisk ist in mehr als 64 ETFs enthalten und somit ein eher allgemein bekannter Wert. Der Spitzenreiter iShares STOXX Europe 600 Health Care UCITS ETF (DE) gewichtet Novo Nordisk mit 9,30% im ETF.
Entdecke die 6 ETFs in denen Novo Nordisk am höchsten gewichtet ist Insgesamt in 64 ETFs enthalten
Dir gefallen die Informationen zu Novo Nordisk?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne ein kostenloses und unverbindliches Depot bei BUX Zero mit der Möglichkeit kostenlos US-Aktien und für einen Euro viele weitere Aktien aus Deutschland, Belgien, Niederlande, sterreich oder UK zu kaufen. Wenn du das über meinen Link machst, bekommen wir beide eine gratis Aktie geschenkt:
Dir gefallen die Informationen zu Novo Nordisk?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn du meine Arbeit unterstützen möchtest, dann eröffne gerne ein kostenloses und unverbindliches Depot bei der ING Diba. Ich erhalte 20 wenn du daraufhin dann zum Beispiel einen Aktien-Sparplan anlegst oder etwas kaufst:
Dir gefallen die Informationen zu Novo Nordisk?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein kostenloses und unverbindliches Depot bei Trade Republic mit der Möglichkeit kostenlos Aktien zu besparen. Wenn du das über meinen Link machst, bekommst du und ich bei deinem ersten Wertpapierkauf 15 von Trade Republic geschenkt:
Dir gefallen die Informationen zu Novo Nordisk?
Galue bleibt auch in Zukunft kostenfrei und ungesponsort. Wenn Ihr meine Arbeit unterstützen möchtet, dann eröffnet gerne ein mindestens 3 Jahre lang kostenloses Depot bei der comdirect. Wenn du das über diesen Link machst unterstützt du auch meine Tochter Zoe, da es Ihr Juniordepot ist. Sie erhält 20 und bei einem aktiven ETF- oder Aktien-Sparplan bleibt dein Depot auch danach kostenfrei:
84 News & Informationen zur Novo Nordisk Aktie
Futures Rise Ahead Of Claims Data; Europe Hits Another Record High
ZeroHedge – On a long enough timeline, the survival rate for everyone drops to zero
3 High Ebitda Margin Ratio Stock Picks
GuruFocus Article or News written by Alberto Abaterusso and the topic is about: These businesses appear to be in a good shape from a financial standpoint
15 Most Valuable Biotech Companies in the World
In this article we will take a look at the 15 most valuable biotech companies in the world. You can skip our detailed analysis of the biotechnology industry…
Dicerna Announces FDA Clearance Of Investigational New Drug (IND) Application For DCR-AUD For The Treatment Of Alcohol Use Disorder
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (“Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)
Continuous Glucose Monitoring Device Market Size Worth $10.36 Billion By 2028: Grand View Research, Inc.
SAN FRANCISCO, July 29, 2021 /PRNewswire/ — The global continuous glucose monitoring device market size is expected to reach USD 10.36 billion by…
Continuous Glucose Monitoring Device Market Size Worth $10.36 Billion By 2028: Grand View Research, Inc.
SAN FRANCISCO, July 29, 2021 /PRNewswire/ — The global continuous glucose monitoring device market size is expected to reach USD 10.36 billion by 2028,
Novo Holdings Leads US$ 118M Series C Investment in Genomatica
– Financing to amplify the scale and impact of Genomatica's sustainable materials- Underscores Novo Holdings' commitment to support the developmen…
First National Bank of Hutchinson Buys iShares 0-5 Year TIPS Bond ETF, MasTec Inc, MYR Group Inc, Sells BTC iShares International Select Dividend ETF, iShares iBoxx USD Investment Grade Corporate Bond
GuruFocus Article or News written by insider and the topic is about:
KCS Wealth Advisory Buys iShares Investment Grade Bond Factor ETF, Vanguard Short-Term Government Bond ETF, Alibaba Group Holding, Sells International Paper Co, Owens-Corning Inc, M/I Homes Inc
GuruFocus Article or News written by insider and the topic is about:
Were Hedge Funds Right About BHP Group (BHP)?
In this article you are going to find out whether hedge funds think BHP Group (NYSE:BHP) is a good investment right now. We like to check what the smart…
10 Most Valuable Companies in Europe
In this article we will take a look at the 10 most valuable companies in Europe. However, you can skip our detailed analysis of these European companies…
Alliance Trust PLC – Half Year Results
Strong performance in H1:2021 Results for six months ended 30 June 2021 Financial highlights As at 6 months to 30 June 2021As at 12 months to 31 Dec…
Worldwide Rapid Acting Insulin Industry to 2027 – Players Include Merck & Co, Sanofi and Novo Nordisk Among Others
/PRNewswire/ — The “Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook, Industry Analysis Report…
Worldwide Rapid Acting Insulin Industry To 2027 – Players Include Merck & Co, Sanofi And Novo Nordisk Among Others
DUBLIN, July 22, 2021 /PRNewswire/ — The “Global Rapid Acting Insulin Market By Product Type, By Indication, By Distribution Channel, By Regional Outlook,
Novo Holdings co-leads Hemab's US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
/PRNewswire/ — Novo Holdings, a leading international life science investor, today announces that it has co-led alongside HealthCap and RA Capital Management…
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
COPENHAGEN, Denmark and BOSTON, July 22, 2021 /PRNewswire/ — Hemab ApS ('Hemab'), a biotech company developing next generation therapeutics for s…
Dicerna Announces Interim Results From Phase 1 Trial Of Belcesiran For Treatment Of Alpha-1 Antitrypsin Deficiency-Associated Liver Disease
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)
Worldwide Diabetes Devices and Drugs Industry to 2026 – Featuring Novo Nordisk, Ypsomed and Abbott Laboratories Among Others
/PRNewswire/ — The “Diabetes Devices and Drugs Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2026” report has been added to…
Global Generic Drugs Market To Reach $507.8 Billion By 2026
SAN FRANCISCO, July 14, 2021 /PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today
Global Generic Drugs Market to Reach $507.8 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Catalyst Biosciences Announces Key Leadership Changes In Its Ongoing Transition To An Integrated Protease Medicines Company
Grant Blouse, Ph.D., M.Sc. appointed chief scientific officer
Tom Knudsen, DVM, Ph.D. promoted to senior vice president, corporate development
Howard
Global Human Growth Hormone Drugs Market to Reach $4 Billion by 2026
/PRNewswire/ — A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled…
Mid-Afternoon Market Update: Dow Surges Over 100 Points; State Auto Financial Shares Jump
Toward the end of trading Monday, the Dow traded up 0.34% to 34,987.02 while the NASDAQ rose 0.08% to 14,713.30. The S&P also rose, gaining 0….
Prothena And Novo Nordisk Announce Acquisition Agreement For Prothena's ATTR Amyloidosis Programme
Prothena is eligible to receive development and sales milestone payments totalling up to 1.2 billion US dollars, including 100 million dollars in upfront and
Novo Nordisk A/S Stock Gives Every Indication Of Being Modestly Overvalued
GuruFocus Article or News written by GF Value and the topic is about:
Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ — Novo Holdings, a global life science investor, today announces that it has co-led the Series A f…
Muna Therapeutics Launches With US$ 73M Series A To Advance Novel Small Molecule Therapeutics For Neurodegenerative Diseases
COPENHAGEN, Denmark, July 9, 2021 /PRNewswire/ — Muna Therapeutics (“Muna”), pioneering the development of first-in-class small molecule therapeutics for
Novo Holdings Launches Muna Therapeutics with US$ 73M Series A to Advance Novel Small Molecule Therapeutics for Neurodegenerative Diseases
/PRNewswire/ — Novo Holdings, a global life science investor, today announces that it has co-led the Series A financing of its portfolio company, Muna…
Renaissance Investment Group LLC Buys 3M Co, Novozymes A/S, iShares Russell Mid-Cap Growth ETF, Sells American Tower Corp, The Walt Disney Co, General Electric Co
GuruFocus Article or News written by insider and the topic is about:
Forget Senseonics, Buy These 3 Diabetes Stocks Instead By StockNews
Forget Senseonics, Buy These 3 Diabetes Stocks Instead
These Are The Top Ten Picks Of Jim Simons
We have referred to the latest available 13F filing to come up with the top ten picks of Jim Simons. Novo Nordisk tops the list.
These Are The Top Ten Picks Of Jim Simons
Jim Simons is one of the greatest investors of all time and is known as the “Quant King.” He founded one of the most successful quant fund…
Dicerna Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dicerna Pharmaceuticals, Inc. (Nasdaq: DRNA) (the “Company” or “Dicerna”), a leading developer of investigational ribonucleic acid interference (RNAi)
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.05% By Investing.com
Denmark stocks lower at close of trade; OMX Copenhagen 20 down 0.05%
Industrial Enzymes Market to Grow Significantly at 6.3% CAGR from 2020 to 2027 – Report by Market Research Future (MRFR)
Industrial Enzymes Market Insights and Industry Analysis by Type (Carbohydrases [Amylase, Glucanase, Cellulase and others], Proteases, Lipases and others),…
Rising Diabetic Patients Pool Prompts High Demand for Smart Insulin Pens, Market Estimated to be valued at US$ 70.4 Mn by 2027 End: TMR
/PRNewswire/ — Smart insulin refers to advanced insulin that is capable to respond automatically to varying blood glucose levels. Thus, higher or lower blood…
Novo Nordisk A S (NVO): Price Now Near $72.19; Daily Chart Shows Downtrend on 50 Day Basis
Global Hematology Drugs Market (2021 to 2030) – COVID-19 Impact and Recovery
/PRNewswire/ — The
Magic Software Enterprises steigert Dividende
Magic Software Enterprises Ltd. (ISIN: IL0010823123, NASDAQ: MGIC) kündigt eine Halbjahresdividende in Höhe von 0,21 US-Dollar je Aktie an und steigert damit die Dividendenausschüttung um 20 Prozent, wie der Konzern am Montag mitteilte. Die Auszahlung erfolgt am 7. April 2021 (Record date: 25. März 2021). Die aktuelle Dividendenrendite liegt damit beim derzeitigen Aktienkurs von 16,08 US-Dollar (Stand: 8. März 2021)
Casey’s General Stores meldet Dividende
Die US-Einzelhandelskette Casey’s General Stores Inc. (ISIN: US1475281036, NASDAQ: CASY) wird eine Quartalsdividende in Höhe von 34 US-Cents je Aktie an ihre Anteilseigner ausschütten, wie am Montag berichtet wurde. Die Auszahlung der Dividende erfolgt am 17. Mai 2021 (Record date ist der 3. Mai 2021). Auf das Jahr hochgerechnet erhalten die Aktionäre 1,36 US-Dollar. Beim aktuellen Kursniveau von 202,21 US-Dollar